VKTX - Novo Nordisk expects Wegovy approval in China this year: report
2024-03-07 19:06:31 ET
More on Novo Nordisk
- Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified
- Novo Nordisk, A Very Healthy Pharma Stalwart
- Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy
- Biggest stock movers today: NYCB, NVO, VSCO, BIG, and more
- Novo Nordisk hits all-time high as oral obesity drug shows promising early results